Lung Cancer
Highlights from AACR 2024: KRYSTAL-1, FLAURA2, and EDGE
This week, we cover key updates from the American Association for Cancer Research (AACR) 2024 Annual Meeting, held in San…
Date: 12th April 2024
Targeted therapies for lung cancer at TTLC 2024
This week, we cover interesting research from TTLC 2024, focusing on innovative treatments for lung cancer. Starting off, Bruna Pellini…
Date: 1st March 2024
Key updates at ESMO Asia 2023
The recent European Society for Medical Oncology (ESMO) Asia 2023 Congress in Singapore, brought together key oncology experts to delve…
Date: 26th January 2024
Highlights in lung cancer from ESMO 2023
The European Society for Medical Oncology Annual Meeting (ESMO) 2023 brought together thousands of experts in oncology to hear new…
Date: 10th November 2023
EGFR exon 20 insertions and how to manage patients in the UK
EGFR exon 20 insertion mutations represent 5% to 10% of EGFR mutations in patients with non-small cell lung cancer (NSCLC)….
Date: 13th October 2023
Latest updates in mesothelioma
In this latest episode from VJOncology, join us as we explore the latest news in mesothelioma research with three distinguished…
Date: 4th August 2023
iwCAR-T Session III: CAR-T clinical advances in lung cancer
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…
Date: 16th June 2023
Liquid biopsy in lung cancer: precision medicine and MRD
In this podcast, we’ll be discussing the use of liquid biopsy in lung cancer, with Professor Klaus Pantel of University…
Date: 28th April 2023
Approaches to NSCLC with or without targetable mutations
In this podcast, we will explore approaches to non-small cell lung cancer (NSCLC) with and without targetable mutations. NSCLC is…
Date: 17th February 2023
Resistance to immune checkpoint inhibitors in NSCLC
In this podcast, we’ll be covering the latest updates on immune checkpoint inhibitor resistance for patients with non-small cell lung…
Date: 13th January 2023
Updates in EGFR-mutant NSCLC
A large proportion of patients with non-small cell lung cancer (NSCLC) have mutations in EGFR, making it a popular target…
Date: 2nd December 2022
The Lung Cancer Sessions: Updates from WCLC 2022
The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…
Date: 2nd September 2022
